Dogwood Therapeutics, Inc. (DWTX)

Dogwood Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	9.61	6.52	14.85	3.32	7.03	14.01
Cash & Short-Term Investments	9.61	6.52	14.85	3.32	7.03	14.01
Cash Growth	-28.30%	-56.06%	347.64%	-52.82%	-49.81%	-52.99%
Prepaid Expenses	0.43	0.75	0.83	0.71	1.18	1.35
Other Current Assets	0.99	1.16	0.86	0.14	0.16	0.42
Total Current Assets	11.03	8.43	16.54	4.17	8.37	15.78
Property, Plant & Equipment	0.14	0.18	0.22	-	-	-
Goodwill	11.96	12.4	11.81	-	-	-
Long-Term Deferred Charges	57.35	69.14	65.71	-	-	-
Other Long-Term Assets	0.02	0.02	0.02	-	-	-
Total Assets	80.5	90.17	94.31	4.17	8.37	15.78

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	0.41	0.76	1.23	0.11	0.57	0.35
Accrued Expenses	2.35	2.24	1.89	0.25	0.47	0.92
Current Portion of Leases	0.06	0.06	0.05	-	-	-
Total Current Liabilities	2.83	3.06	3.18	0.36	1.04	1.28
Long-Term Debt	-	-	15.38	-	-	-
Long-Term Leases	0.07	0.11	0.15	-	-	-
Long-Term Deferred Tax Liabilities	9.2	12.11	11.31	-	-	-
Total Liabilities	12.13	15.27	30.03	0.36	1.04	1.28

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	196.25	183.86	67.86	65.58	63.5	58.43
Retained Earnings	-124.59	-108.08	-73.82	-61.47	-56.17	-43.93
Treasury Stock	-0.3	-0.3	-0.3	-0.3	-	-
Comprehensive Income & Other	-2.99	-0.59	-3.86	-	-	-
Total Common Equity	68.37	74.9	-10.12	3.81	7.33	14.5
Shareholders' Equity	68.37	74.9	64.28	3.81	7.33	14.5
Total Liabilities & Equity	80.5	90.17	94.31	4.17	8.37	15.78

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	0.13	0.16	15.59	-	-	-
Net Cash (Debt)	9.48	6.36	-0.74	3.32	7.03	14.01
Net Cash Growth	-28.25%	-	-	-52.82%	-49.81%	-52.99%
Net Cash Per Share	0.45	1.28	-0.72	4.42	15.88	42.04
Filing Date Shares Outstanding	33.99	33.4	1.91	0.77	0.73	0.33
Total Common Shares Outstanding	33.63	29.74	1.33	0.77	0.73	0.33
Working Capital	8.19	5.37	13.37	3.81	7.33	14.5
Book Value Per Share	2.03	2.52	-7.60	4.94	9.99	43.52
Tangible Book Value	56.4	62.5	-21.94	3.81	7.33	14.5
Tangible Book Value Per Share	1.68	2.10	-16.47	4.94	9.99	43.52
Machinery	0.01	0.01	0.02	-	-	-

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 29, 2026

Data Sources Report a data error